NIM
WST icon

NEOS Investment Management’s West Pharmaceutical WST Stock Holding History

NEOS Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.05M Buy
11,268
+1,453
+15% +$444K 0.01% 404
2026
Q1 		$2.46M Buy
9,815
+5,562
+131% +$1.38M 0.01% 465
2025
Q4 		$1.17M Buy
4,253
+7
+0.2% +$1.92K 0.01% 532
2025
Q3 		$1.11M Buy
4,246
+1,302
+44% +$316K 0.01% 503
2025
Q2 		$644K Sell
2,944
-291
-9% -$62.2K 0.01% 516
2025
Q1 		$724K Sell
3,235
-910
-22% -$251K 0.01% 477
2024
Q4 		$1.36M Sell
4,145
-202
-5% -$63.6K 0.03% 351
2024
Q3 		$1.3M Sell
4,347
-1,096
-20% -$336K 0.04% 328
2024
Q2 		$1.79M Buy
5,443
+1,298
+31% +$459K 0.07% 232
2024
Q1 		$1.64M Buy
4,145
+2,180
+111% +$806K 0.1% 191
2023
Q4 		$692K Buy
1,965
+1,220
+164% +$432K 0.07% 228
2023
Q3 		$280K Buy
+745
New +$288K 0.04% 292

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

NEOS Investment Management's WST Position: Q2 2026 in Review

NEOS Investment Management increased its West Pharmaceutical (WST) stake by 15% in Q2 2026, buying an estimated $444K and bringing the position to 11,268 shares worth $4.05M. The position accounts for 0.01% of the portfolio, ranked #404.

NEOS Investment Management first reported a position in WST in Q3 2023 and has held it in 12 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • NEOS Investment Management held 11,268 shares of West Pharmaceutical worth $4.05M as of Q2 2026.
  • NEOS Investment Management bought 1,453 West Pharmaceutical shares in Q2 2026, an estimated $444K.
  • West Pharmaceutical made up 0.01% of NEOS Investment Management's portfolio in Q2 2026, its #404 holding.
  • NEOS Investment Management first reported a position in West Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.